HEALTH.2012.2.4.5-1
HEALTH.2012.2.4.5-1
7 projects · €31,920,814 total EU contribution (project-level) · 30 participating organizations · 12 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€31,920,814
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (7)
- Spain (6)
- SE (3)
- CH (2)
- DK (2)
- France (2)
- IL (2)
- AT (1)
- BE (1)
- Italy (1)
- Netherlands (1)
- UK (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Neurotrophic Cochlear Implant for Severe Hearing Loss NeuEar · 304930 | FP7 | €5,843,872 | €8,335,282 | Details |
A novel micronutrient-based strategy to prevent hearing impairments: test and road to market for age-related hearing loss and preservation of residual hearing PROHEARING · 304925 | FP7 | €5,096,600 | €6,698,102 | Details |
High-resolution image-based computational inner ear modelling for surgical planning of cochlear implantation HEAR-EU · 304857 | FP7 | €3,551,285 | €4,737,501 | Details |
Advancing Binaural Cochlear Implant Technology ABCIT · 304912 | FP7 | €4,000,000 | €5,279,350 | Details |
Preclinical development of drugs and drug delivery technology for the treatment of inherited photoreceptor degeneration DRUGSFORD · 304963 | FP7 | €4,971,428 | €6,552,814 | Details |
Preclinical proof of concept of AF243 potency to prevent and/or treat sensorineural hearing loss AFHELO · 304900 | FP7 | €2,796,376 | €3,602,529 | Details |
Prolonged inhibition of semaphorine3a pathway via a bio-degradable implant towards a better therapy for visual sensory impairments VISION · 304884 | FP7 | €5,661,253 | €7,413,800 | Details |